Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 10OTHER_GOV 2NIH 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Stomach Neoplasms 4Esophageal Neoplasms 2Colorectal Neoplasms 2Rectal Neoplasms 1Hypertension 1Endoscopic Submucosal Dissection 1Duodenal Neoplasms 1Diabetes Mellitus 1Colonic Neoplasms 1

Interventions

Paclitaxel 7Cisplatin 6Radiation 4Carboplatin 4tislelizumab 3Surgical Procedures, Operative 3Radiotherapy 3Immune Checkpoint Inhibitors 3Capecitabine 3camrelizumab 2Platinum Compounds 2Endoscopic Mucosal Resection 2Drug Therapy 2Albumin-Bound Paclitaxel 2nedaplatin 1lobaplatin 1Tranexamic Acid 1Thalidomide 1TP protocol 1Stents 1Standard of Care 1Oxaliplatin 1Nutrition Assessment 1Neoadjuvant Therapy 1Muscle Stretching Exercises 1Indocyanine Green 1Heart Rate 1Fluorouracil 1Exercise 1Epinephrine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER_GOV × Esophageal Neoplasms × Endoscopic Mucosal Resection × Clear all
NCT04780256 2025-10-03

Endoscopic Resection of Gastrointestinal Neoplasms

Azienda USL Reggio Emilia - IRCCS

Recruiting
2,000 enrolled
Gastrointestinal

Colonic Neoplasms, Duodenal Neoplasms, Esophageal Neoplasms, Stomach Neoplasms

NCT06979986 2025-05-20

SLND Versus Non-Dissection Following ESD for T1a Stage Esophageal Squamous Cell Carcinoma

Fujian Cancer Hospital

Phase NA Not yet recruiting
102 enrolled
Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡